Clinical trial Nivothym
Single-arm, multicenter, phase II study of nivolumab in patients with type B3 thymoma and thymic carcinoma previously treated with chemotherapy - (Nivothym)
| Cancers | |
|---|---|
| Organ | Thymus |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | EORTC |
| EudraCT Identifier | 2015-005504-28 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03134118 |
| Inclusion criteria | second line metastatic |
| Last update |